Archives of Rheumatology
Scope & Guideline
Connecting global minds to transform rheumatologic care.
Introduction
Aims and Scopes
- Rheumatic Diseases and Their Management:
A core focus on the diagnosis, treatment, and management strategies for various rheumatic diseases including rheumatoid arthritis, systemic lupus erythematosus, and psoriatic arthritis. - Patient-Centered Research:
Emphasis on studies exploring patient experiences, quality of life, and health literacy in relation to rheumatic diseases, aiming to enhance patient care. - Innovative Therapeutic Approaches:
Exploration of novel therapeutic interventions, including biological agents, small molecules, and other treatment modalities for rheumatic conditions. - Comorbidities and Systemic Implications:
Research on the systemic effects of rheumatic diseases and their associations with comorbidities such as cardiovascular diseases, metabolic syndrome, and psychological factors. - Epidemiological Studies:
Focus on the epidemiology of rheumatic diseases, including prevalence, risk factors, and demographic studies to inform public health approaches. - Diagnostic Advances:
Investigations into the diagnostic tools and methodologies for more accurate and timely diagnosis of rheumatic diseases. - Multidisciplinary Approaches:
Encouragement of interdisciplinary research that integrates various scientific fields to address complex issues in rheumatology.
Trending and Emerging
- Impact of COVID-19 on Rheumatic Diseases:
An increasing number of studies addressing the implications of the COVID-19 pandemic on rheumatic disease management, vaccination responses, and patient outcomes, highlighting the need for adaptive strategies in rheumatology. - Biomarkers and Personalized Medicine:
A trend towards identifying biomarkers for disease activity and treatment response, reflecting a shift towards personalized medicine in rheumatology. - Multidisciplinary Care Approaches:
Growing literature on the integration of various healthcare disciplines, including psychology and nutrition, in managing rheumatic diseases, emphasizing a holistic approach to patient care. - Telemedicine and Remote Monitoring:
Emerging interest in telemedicine and remote monitoring tools for managing rheumatic diseases, especially in the context of the ongoing pandemic and the need for accessible healthcare. - Psychosocial Aspects of Rheumatic Diseases:
Increased focus on the psychosocial factors affecting patients with rheumatic diseases, including mental health, quality of life, and patient education. - Epidemiological and Public Health Research:
A notable rise in research examining the epidemiological aspects of rheumatic diseases, including risk factors, prevalence, and population health implications.
Declining or Waning
- Traditional Clinical Trials:
There appears to be a decrease in classical randomized controlled trials for established treatments, as the field shifts towards real-world evidence and observational studies. - Single-Disease Focus Studies:
Research focusing solely on individual rheumatic diseases without considering comorbidities or systemic implications is becoming less prevalent, reflecting a broader interest in holistic patient care. - Basic Science Investigations:
There is a waning interest in basic science studies that do not translate to clinical applications, as the journal prioritizes research with direct implications for patient care. - Static Diagnostic Criteria Studies:
Research solely focused on validating static diagnostic criteria is diminishing, as more emphasis is placed on dynamic and personalized approaches to diagnosis.
Similar Journals
Advances in Rheumatology
To innovate, educate, and transform rheumatology.Advances in Rheumatology is a premier open-access journal published by BMC, dedicated to advancing the field of rheumatology through high-quality, peer-reviewed research. Launched in 2018, the journal has quickly established itself within the academic community, achieving a commendable Q2 ranking in the category of Rheumatology as of 2023 and ranking #34 out of 73 in the Scopus Medicine Rheumatology listings, placing it in the 54th percentile. With a focus on innovative treatments, patient care, and the latest in rheumatological research, the journal provides a platform for researchers and clinicians to disseminate their findings and foster collaborative advancements in this critical area of medicine. Recognized for its accessibility, the journal follows an open-access model, ensuring that research is freely available to a global audience. With a commitment to high standards of academic rigor, Advances in Rheumatology plays a vital role in enhancing the understanding and treatment of rheumatic diseases, making it an invaluable resource for researchers, professionals, and students alike.
ZEITSCHRIFT FUR RHEUMATOLOGIE
Innovating the future of rheumatology through scholarly discourse.ZEITSCHRIFT FUR RHEUMATOLOGIE, published by Springer Heidelberg, serves as a vital platform in the field of rheumatology, providing researchers, clinicians, and students with cutting-edge findings and discussions related to the diagnosis, treatment, and management of rheumatic diseases. Since its inception in 1974 and continuing until 2024, this journal retains its commitment to disseminating significant scientific work within this specialized domain. Although it is currently categorized in the Q4 quartile for Rheumatology and ranks 47 out of 73 in Scopus, reflecting its burgeoning presence, the journal is dedicated to evolving and gaining prominence in the academic community. By offering valuable insights and fostering scholarly discourse, ZEITSCHRIFT FUR RHEUMATOLOGIE plays a crucial role in advancing rheumatology research and enhancing patient care practices worldwide. The journal presents an opportunity for its readers to engage with contemporary studies and enrich their understanding of rheumatic ailments.
Reumatologia
Enhancing visibility of crucial research in Rheumatology.Reumatologia is a dedicated open-access journal published by TERMEDIA PUBLISHING HOUSE LTD that has been serving the global scientific community since 2005. The journal focuses on the fields of Rheumatology, Immunology, and Allergy, providing a rich platform for researchers and practitioners to share innovative findings, clinical insights, and methodologies. With its roots tracing back to the early 1960s and a steady convergence of quality content through 2024, Reumatologia has secured a place in the academic landscape, currently holding a Q4 rating in Immunology and a Q3 rating in both Immunology and Allergy and Rheumatology categories for 2023. While the journal ranks #42 out of 73 in the Medicine - Rheumatology category, its open-access model ensures that research is widely disseminated, enhancing visibility and accessibility to vital knowledge that shapes therapeutic practices. Located in Poznan, Poland, Reumatologia remains a pivotal source of credible research, fostering collaboration among academics, healthcare professionals, and students internationally.
JOURNAL OF RHEUMATOLOGY
Advancing the Frontiers of Rheumatology and ImmunologyJOURNAL OF RHEUMATOLOGY, published by the J Rheumatol Publ Co, stands as a distinguished platform within the fields of rheumatology and immunology since its inception in 1974. With an impressive impact evidenced by its 2023 rankings—Q1 in Rheumatology and Q2 in both Immunology and Allergy—the journal has secured its position as a vital resource for researchers and practitioners alike. The journal is dedicated to advancing clinical and experimental knowledge in the pathogenesis, diagnosis, and management of rheumatic diseases, providing a rich repository of peer-reviewed articles that drive innovation in treatment protocols and patient care. Although it operates under a subscription model, the journal remains accessible to a broad audience committed to advancing their understanding of these critical areas. Located in Toronto, Canada, it continues to attract contributions from leading experts globally, making it an essential read for anyone keen on staying at the forefront of rheumatological research and practice.
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
Elevating patient care with cutting-edge insights.Rheumatic Disease Clinics of North America is a premier journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of rheumatology through comprehensive and impactful research. With an ISSN of 0889-857X and an E-ISSN of 1558-3163, this esteemed publication has been disseminating knowledge since its inception in 1987, and continues to guide clinicians and researchers alike through its insightful articles and case studies. Positioned in the 2023 Q2 quartile for Rheumatology, it ranks #31 out of 73 journals in the Scopus category of Medicine _ Rheumatology, reflecting a commendable impact factor and relevance in the academic community. Although it does not offer open access options, the journal ensures that subscribers have access to cutting-edge research and reviews that address contemporary challenges and advancements in rheumatic disease. With its authoritative content, Rheumatic Disease Clinics of North America serves as a vital resource for those striving to improve patient care and clinical outcomes in the ever-evolving landscape of rheumatology research.
International Journal of Rheumatic Diseases
Illuminating the complexities of rheumatic diseases.The International Journal of Rheumatic Diseases, published by WILEY, serves as a crucial platform for disseminating high-quality research and advancements in the field of rheumatology. With an ISSN of 1756-1841 and an E-ISSN of 1756-185X, this journal has established itself within the academic community since its inception in 2008, and it is set to continue until at least 2024. Positioned in the Q3 category of rheumatology, the journal holds a significant rank of #38 out of 73 in its field according to Scopus, showcasing its growing influence despite the competitive environment. The absence of Open Access reflects a traditional scholarly publishing model, allowing for meticulous peer-review processes to ensure the rigor and reliability of published studies. This journal aims to foster innovative research, critical reviews, and clinical studies, thereby contributing to a deeper understanding of rheumatic diseases and enhancing patient care. The dedicated readership, including researchers, healthcare professionals, and students, will find valuable insights into the latest findings and methodologies relevant to rheumatology in the journal's comprehensive articles.
Rheumatology Advances in Practice
Empowering rheumatology through innovation and education.Rheumatology Advances in Practice, published by Oxford University Press, is a vital open-access journal dedicated to advancing research and education in the field of rheumatology. With an E-ISSN of 2514-1775 and an impressive open access model established since 2017, this journal facilitates the dissemination of cutting-edge knowledge and innovative practices to a global audience. It has garnered recognition within the academic community, holding a Q3 classification in Rheumatology for 2023, which reflects its contribution to the evolving landscape of rheumatological research. The journal aims to present high-quality, peer-reviewed articles that explore the latest findings, advancements, and clinical applications in rheumatology, making it an essential resource for researchers, healthcare professionals, and students alike. By bridging the gap between research and practice, Rheumatology Advances in Practice plays a significant role in improving the care of patients with rheumatological conditions, promoting evidence-based approaches to clinical challenges.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
Pioneering insights for the future of patient care.CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is a prestigious journal published by CLINICAL & EXPER RHEUMATOLOGY, dedicated to advancing the field of rheumatology and immunology. With a rich history dating back to 1983, the journal serves as a critical platform for researchers, clinicians, and professionals seeking to disseminate and discuss innovative findings in these rapidly evolving areas. Featuring an impressive Q2 ranking in both Immunology and Allergy, as well as Rheumatology, this journal is recognized for its high-quality contributions, placing it among the top tier of academic publications. Operating without an open access model, CLINICAL AND EXPERIMENTAL RHEUMATOLOGY is headquartered in Pisa, Italy, and publishes articles that undergo rigorous peer review to ensure excellence in research. This journal is an invaluable resource for those dedicated to improving patient outcomes through evidence-based practice in rheumatology, immunology, and related fields.
JCR-JOURNAL OF CLINICAL RHEUMATOLOGY
Empowering Professionals Through Cutting-edge ResearchJCR-Journal of Clinical Rheumatology, published by Lippincott Williams & Wilkins, is a premier outlet dedicated to the field of rheumatology, recognized for its contributions and relevance among medical journals. Boasting an impact factor reflective of its vital role in disseminating innovative research, it currently holds a Q2 category ranking in Medicine (miscellaneous) and a Q3 ranking in Rheumatology as of 2023. With its convergence years spanning from 1995 to 2024, the journal aims to foster the advancement of knowledge in clinical practices, therapeutic advances, and patient management strategies concerning rheumatic diseases. Researchers, professionals, and students can access a wealth of benchmark studies and peer-reviewed articles, enhancing their understanding and collaboration within this dynamic field. By bridging clinical insights with rigorous research, the JCR-Journal of Clinical Rheumatology remains an important resource for advancing the understanding of rheumatologic disorders and improving patient care.
Journal of Rheumatic Diseases
Leading the way in innovative therapeutic strategies and diagnostics.Journal of Rheumatic Diseases, published by the Korean College of Rheumatology, stands as a pivotal platform in the field of rheumatology, contributing significantly to the advancement of knowledge and clinical practice since its inception. With an impact factor reflecting its esteemed position in the academic community, this open-access journal promotes accessibility to high-quality research, ensuring that groundbreaking discoveries are reachable to all stakeholders in the realm of rheumatic diseases. The journal has maintained its commitment to quality, evidenced by its ranking in the Q3 category for Rheumatology in 2023, and its presence among the top quartiles of medical research. Focusing on innovative therapeutic approaches, emerging diagnostic techniques, and comprehensive reviews, the Journal of Rheumatic Diseases seeks to foster collaboration and dialogue among researchers, clinicians, and students alike. For accessibility, the journal offers numerous articles since its transition to open access in 2017, thereby facilitating research dissemination across the globe. As it converges over the years from 2019 to 2024, the journal promises to be instrumental in shaping the future of rheumatic disease research, inviting contributions that inspire new frontiers in this essential field.